Skip to Main Content

Author Details

Huichun Zhan
Stony Brook School of Medicine
2005
34
14
Prashant Mali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36906169ChatGPT in Scientific Writing: A Cautionary Tale.Am J Med2023
37503259Unlocking the Role of Endothelial MPL Receptor and JAK2V617F Mutation: Insights into Cardiovascular Dysfunction in MPNs and CHIP.bioRxiv2023
37162918Deciphering the Differential Impact of Thrombopoietin/MPL Signaling on Hematopoietic Stem Cell Function in Bone Marrow and Spleen.bioRxiv2023
36875914Cardio-Oncology Guidelines and Strength of the Evidence.JACC CardioOncol2023
35260895JAK2V617F Mutant Megakaryocytes Contribute to Hematopoietic Aging in a Murine Model of Myeloproliferative Neoplasm.Stem Cells2022
35814384Megakaryocytes as the Regulator of the Hematopoietic Vascular Niche.Front Oncol2022
36505825Editorial: Megakaryocytes as regulators of tumor microenvironments.Front Oncol2022
34139651JAK2V617F mutant endothelial cells promote neoplastic hematopoiesis in a mixed vascular microenvironment.Blood Cells Mol Dis2021
34765558A Murine Model With JAK2V617F Expression in Both Hematopoietic Cells and Vascular Endothelial Cells Recapitulates the Key Features of Human Myeloproliferative Neoplasm.Front Oncol2021
34666822Cell competition between wild-type and JAK2V617F mutant cells prevents disease relapse after stem cell transplantation in a murine model of myeloproliferative neoplasm.Exp Hematol Oncol2021
34153382Cell competition between wild-type and JAK2V617F mutant cells in a murine model of a myeloproliferative neoplasm.Exp Hematol2021
30767234The marrow stem cell niche in normal and malignant hematopoiesis.Ann N Y Acad Sci2020
33119879The Hematopoietic Microenvironment in Myeloproliferative Neoplasms: The Interplay Between Nature (Stem Cells) and Nurture (the Niche).Adv Exp Med Biol2020
32920974Endothelial JAK2V617F mutation leads to thrombosis, vasculopathy, and cardiomyopathy in a murine model of myeloproliferative neoplasm.J Thromb Haemost2020
30593829Functional interdependence of hematopoietic stem cells and their niche in oncogene promotion of myeloproliferative neoplasms: the 159th biomedical version of "it takes two to tango".Exp Hematol2019
30744617Leukemia relapse after transplantation - a consensus on monitoring, prevention, and treatment in China.BMC Med2019
28744010The JAK2V617F-bearing vascular niche promotes clonal expansion in myeloproliferative neoplasms.Leukemia2018
29970351The regulation of normal and neoplastic hematopoiesis is dependent on microenvironmental cells.Adv Biol Regul2018
30005133JAK2V617F Megakaryocytes Promote Hematopoietic Stem/Progenitor Cell Expansion in Mice Through Thrombopoietin/MPL Signaling.Stem Cells2018
29567773<i>JAK2V617F</i>-bearing vascular niche enhances malignant hematopoietic regeneration following radiation injury.Haematologica2018
27133820JAK2<sup>V617F</sup>-mutant megakaryocytes contribute to hematopoietic stem/progenitor cell expansion in a model of murine myeloproliferation.Leukemia2016
27865175JAK2<sup>V617F</sup>-mutant vascular niche contributes to JAK2<sup>V617F</sup> clonal expansion in myeloproliferative neoplasms.Blood Cells Mol Dis2016
26227854Targeting glutamine metabolism in myeloproliferative neoplasms.Blood Cells Mol Dis2015
23265742MicroRNA deregulation in polycythemia vera and essential thrombocythemia patients.Blood Cells Mol Dis2013
23432162MicroRNAs in myeloproliferative neoplasms.Br J Haematol2013
20103008Acute cardiomyopathy in a patient with thrombotic thrombocytopenic purpura.Am J Med2010
20003052Thrombotic thrombocytopenic purpura at the Johns Hopkins Hospital from 1992 to 2008: clinical outcomes and risk factors for relapse.Transfusion2010
19521323The diagnosis and management of polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the JAK2 V617F era.Clin Adv Hematol Oncol2009
19797525Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders.Blood2009
16955464Late relapse of acute promyelocytic leukemia in a patient with no maintenance therapy.Am J Hematol2007
17645375The role of topical cyclo-oxygenase-2 inhibitors in skin cancer: treatment and prevention.Am J Clin Dermatol2007
17227970Fixed-dose unfractionated heparin vs low-molecular-weight heparin for venous thromboembolism.JAMA2007
16528808Sleep apnea and heart disease.N Engl J Med2006
15917393Surgery for asymptomatic mitral regurgitation.N Engl J Med2005
  • 1 - 34 of 34

Recommended Authors

Zhijie Wu
and Blood Institute, National Institutes of Health
Career Start Year 2013
Number of shared co-authors 0
Alexa J Siddon
Yale School of Medicine
Career Start Year 2010
Number of shared co-authors 0
Dongqing Yan
Inner Mongolia University
Career Start Year 2010
Number of shared co-authors 0
Anthony D Pomicter
Huntsman Cancer Institute, University of Utah
Career Start Year 2009
Number of shared co-authors 0
Friedrich St??lzel
University Hospital TU Dresden
Career Start Year 2008
Number of shared co-authors 0
Jennifer Dunlap
Oregon Health & Science University
Career Start Year 2008
Number of shared co-authors 0
Paulo Vidal Campregher
Hospital Israelita Albert Einstein
Career Start Year 2007
Number of shared co-authors 0
Christopher Y Park
NYU Robert I. Grossman School of Medicine
Career Start Year 2006
Number of shared co-authors 0
Naseema Gangat
Mayo Clinic
Career Start Year 2004
Number of shared co-authors 0
Fumio Nakahara
Graduate School of Medicine, The University of Tokyo
Career Start Year 2004
Number of shared co-authors 0
Christopher R Cogle
College of Medicine, University of Florida
Career Start Year 2003
Number of shared co-authors 0
Stephen T Oh
Washington University School of Medicine
Career Start Year 2001
Number of shared co-authors 1
Peter Kurre
Children's Hospital of Philadelphia
Career Start Year 1999
Number of shared co-authors 0
Xingmin Feng
and Blood Institute, National Institutes of Health
Career Start Year 1999
Number of shared co-authors 0
Ravindra Majeti
Stanford University School of Medicine
Career Start Year 1998
Number of shared co-authors 0
Angela G Fleischman
University of California Irvine
Career Start Year 1998
Number of shared co-authors 0
David P Steensma
Novartis Institutes for BioMedical Research
Career Start Year 1997
Number of shared co-authors 0
Stephanie Halene
Smilow Cancer Center, Yale University School of Medicine
Career Start Year 1997
Number of shared co-authors 0
Luca Malcovati
University of Pavia & S. Matteo Hospital
Career Start Year 1997
Number of shared co-authors 0
Robert Kralovics
Medical University of Vienna
Career Start Year 1995
Number of shared co-authors 0
Michael W Becker
James P. Wilmot Cancer Institute, University of Rochester Medical Center Rochester
Career Start Year 1992
Number of shared co-authors 0
Marc M Loriaux
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 1991
Number of shared co-authors 0
Peter Westervelt
Washington University School of Medicine
Career Start Year 1990
Number of shared co-authors 0
Jose A Cancelas
Cincinnati Children's Hospital Medical Center
Career Start Year 1990
Number of shared co-authors 0
Jason Gotlib
Stanford University School of Medicine
Career Start Year 1989
Number of shared co-authors 1
Richard J Jones
Sidney Kimmel Cancer Center, Johns Hopkins University
Career Start Year 1986
Number of shared co-authors 6
Kenneth B Miller
Tufts Medical Center
Career Start Year 1981
Number of shared co-authors 0
Ulrich D??hrsen
University Hospital Essen, University of Duisburg-Essen
Career Start Year 1979
Number of shared co-authors 0
John F DiPersio
Washington University School of Medicine
Career Start Year 1978
Number of shared co-authors 1
Curt I Civin
Center for Stem Cell Biology & Regenerative Medicine and.
Career Start Year 1976
Number of shared co-authors 4

Collaborators

Alison R Moliterno
Johns Hopkins Hospital
Co-authored papers 3
Jerry L Spivak
The Johns Hopkins University School of Medicine
Co-authored papers 3
Chi V Dang
Johns Hopkins University School of Medicine
Co-authored papers 2
Wayne Yu
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
Co-authored papers 1
Linzhao Cheng
Johns Hopkins University School of Medicine
Co-authored papers 1
Prashant Mali (CM4AI)
University of California San Diego
Co-authored papers 1
Yoon-Young Jang
Daegu Catholic University Medical Center, Catholic University of Daegu
Co-authored papers 1
Donna M Williams
Johns Hopkins University School of Medicine
Co-authored papers 1
Sarah N Dowey
Johns Hopkins University School of Medicine, Institute for Cell Engineering
Co-authored papers 1
Zhaohui Ye
Center for Biologics Evaluation and Research
Co-authored papers 1
Release 1.2